v3.26.1
Consolidated Statements of Operations and Comprehensive Income - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Defined Benefit Plan Disclosure [Line Items]        
Revenues from external customers $ 49,188,068 $ 43,358,847 $ 92,248,630 $ 90,687,548
Cost of revenues (including cost of revenues from related parties of $138,593 and $4,669,602 for the three months ended June 30, 2026 and 2025, and $262,982 and $8,126,530 for the six months ended June 30, 2026 and 2025, respectively 13,210,752 13,348,270 25,924,580 22,943,887
Gross profit 35,977,316 30,010,577 66,324,050 67,743,661
Operating expenses:        
Selling, general and administrative expenses (including selling, general and administrative expenses from related parties of $341,510 and $415,767 for the three months ended June 30, 2026 and 2025, and $684,903 and $415,767 for the six months ended June 30, 2026 and 2025, respectively) 17,016,766 15,456,385 29,643,485 28,987,395
Total operating expenses 17,016,766 15,456,385 29,643,485 28,987,395
Income from operations 18,960,550 14,554,192 36,680,565 38,756,266
Other income (expenses):        
Interest income 8,520 22,882 129,889 78,215
Interest expense (128,629) (49,651) (243,435) (55,858)
Foreign currency exchange gain (loss), net 1,032,259 (769,720) 1,893,937 (1,828,246)
Other income 137,056 145,403 628,620 296,731
Other expenses (455,070) (362,745) (678,279) (1,001,478)
Gain on redemption of life insurance policies 0 0 0 8,746,138
Total other income 594,136 (1,013,831) 1,730,732 6,235,502
Income before income taxes and equity in losses of equity method investees 19,554,686 13,540,361 38,411,297 44,991,768
Income tax expense 7,823,743 11,100,509 15,351,334 21,059,966
Equity in losses of equity method investees, net of tax (568,652) 0 (568,652) 0
Net income 11,162,291 2,439,852 22,491,311 23,931,802
Less: net income (loss) attributable to non-controlling interests 469,469 (18,388) 490,418 (28,884)
Net income attributable to SBC Medical Group Holdings Incorporated 10,692,822 2,458,240 22,000,893 23,960,686
Other comprehensive income (loss):        
Foreign currency translation adjustment (5,319,471) 8,623,269 (9,569,020) 18,431,596
Total comprehensive income 5,842,820 11,063,121 12,922,291 42,363,398
Less: comprehensive income (loss) attributable to non-controlling interests 198,369 184,411 216,664 147,579
Comprehensive income attributable to SBC Medical Group Holdings Incorporated $ 5,644,451 $ 10,878,710 $ 12,705,627 $ 42,215,819
Net income per share attributable to SBC Medical Group Holdings Incorporated        
Net income per share attributable to SBC Medical Group Holdings Incorporated - Basic $ 0.1 $ 0.02 $ 0.21 $ 0.23
Net income per share attributable to SBC Medical Group Holdings Incorporated - Diluted $ 0.1 $ 0.02 $ 0.21 $ 0.23
Weighted average shares outstanding        
Weighted average shares outstanding - Basic 102,576,943 103,507,249 102,576,943 103,392,580
Weighted average shares outstanding - Diluted 102,576,943 103,507,249 102,576,943 103,392,580
Related Party [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Revenues from external customers $ 43,732,194 $ 38,944,898 $ 81,687,254 $ 84,202,043
Cost of revenues (including cost of revenues from related parties of $138,593 and $4,669,602 for the three months ended June 30, 2026 and 2025, and $262,982 and $8,126,530 for the six months ended June 30, 2026 and 2025, respectively 138,593 4,669,602 262,982 8,126,530
Operating expenses:        
Total operating expenses 341,510 415,767 684,903 415,767
Nonrelated Party [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Revenues from external customers $ 5,455,874 $ 4,413,949 $ 10,561,376 $ 6,485,505